A Clinical Study on the Analysis of Risk Factors for the Occurrence of PD-1/PD-L1 Inhibitor-associated Liver Injury in Lung Cancer Patients

NCT06402981 · clinicaltrials.gov ↗

RECRUITING

Status

2000

Enrollment

OTHER

Sponsor class

Conditions

Immune Checkpoint Inhibitors
Liver Injury

Interventions

OTHER: High risk prediction model for liver injury

Sponsor

Zhejiang University